Stage IV lung cancer
Showing 26 - 50 of >10,000
Non Small Cell Lung Cancer Metastatic Trial (MRI)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- MRI
- (no location specified)
May 16, 2023
Activating ALK Gene Mutation Negative, Activating EGFR Gene Mutation Negative, Activating ROS1 Gene Mutation Negative Trial in
Completed
- Activating ALK Gene Mutation Negative
- +7 more
- Counseling
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022
Small Cell Lung Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Winston-Salem (Gemcitabine,
Completed
- Small Cell Lung Carcinoma
- +3 more
- Gemcitabine
- Nivolumab
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Sep 6, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Tampa
Recruiting
- Lung Non-Small Cell Carcinoma
- +4 more
- Carboplatin
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Aug 16, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Adenosine A2B Receptor Antagonist PBF-1129
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 1, 2023
Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Lung Non-Squamous Non-Small Cell Carcinoma
- +3 more
- CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
- Sargramostim
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 11, 2022
Advanced Lung Carcinoma, Stage III Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Jacksonville (Best Practice,
Recruiting
- Advanced Lung Carcinoma
- +2 more
- Best Practice
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 6, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Trial in United States
Recruiting
- Lung Non-Small Cell Carcinoma
- +5 more
- Osimertinib
- +2 more
-
San Francisco, California
- +3 more
Aug 17, 2022
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston
Active, not recruiting
- Advanced Colorectal Carcinoma
- +24 more
- Danvatirsen
- Durvalumab
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
NSCLC (NSCLC), Stage IV Trial in Switzerland (Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy),
Not yet recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Stage IV
- Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
- +2 more
-
Aarau, Switzerland
- +7 more
Oct 27, 2023
Double-dose Furmonertinib in Treatment of Slow
Not yet recruiting
- Non Small Cell Lung Cancer
- +3 more
- (no location specified)
Oct 31, 2023
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +12 more
- Nivolumab
- Sapanisertib
- (no location specified)
May 24, 2022
NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)
Not yet recruiting
- Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
- tereotactic body radiotherapy
- (no location specified)
Dec 1, 2023
Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +2 more
- Osimertinib
- Telaglenastat Hydrochloride
-
Birmingham, Alabama
- +10 more
Jan 25, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Carcinoma Trial in Columbus (Health
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +7 more
- Health Education
- Questionnaire Administration
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 18, 2022
Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Necitumumab
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +41 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Hematopoietic and Lymphoid Cell Tumor
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +13 more
- Bintrafusp Alfa
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Glioma Trial in Los Angeles (Computed
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +19 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 19, 2022
Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +9 more
- Biopsy
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 2, 2022
Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)
Not yet recruiting
- Stage IIIB(N2) Non-small Cell Lung Cancer
- +3 more
- Pembrolizumab 200 mg IV infusion
-
Beijing, Beijing, ChinaPeking University
May 30, 2023
Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States
Recruiting
- Leptomeningeal Neoplasm
- +6 more
- Sapanisertib
- Telaglenastat Hydrochloride
-
Duarte, California
- +6 more
Dec 29, 2022
Lung Cancer, NSCLC Trial in Tampa (Vorinostat, Pembrolizumab)
Active, not recruiting
- Lung Cancer
- Non-small Cell Lung Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022
Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Columbus
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 14, 2022
Metastatic Lung Non-Small Cell Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Orange,
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +8 more
-
Orange, California
- +2 more
Aug 10, 2022